Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Kangxi Biotechnology is a specialized biotechnology company dedicated to the research, development, and manufacturing of probiotics and microbial fermentation products. Based in Guangzhou, China, the company operates a state-of-the-art probiotic research institute and a GMP-certified manufacturing facility. Their business model encompasses the entire value chain, from strain screening and functional characterization to the production of high-activity probiotic powders and finished supplements. As a key player in the Chinese microbiome sector, they provide OEM and ODM services to global health brands, focusing on therapeutic areas such as gastrointestinal health, immune modulation, and metabolic regulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Kangxi Biotechnology.